Molecular signature of primary retinal pigment epithelium and stem-cell-derived RPE cells.
about
Stem cells in retinal regeneration: past, present and futureStem cell treatment of degenerative eye diseaseUsing human induced pluripotent stem cells to treat retinal diseaseInduced Pluripotent Stem Cells: Development in the Ophthalmologic FieldProgress of stem/progenitor cell-based therapy for retinal degenerationRescue of enzymatic function for disease-associated RPE65 proteins containing various missense mutations in non-active sites.A multiplex high-throughput gene expression assay to simultaneously detect disease and functional markers in induced pluripotent stem cell-derived retinal pigment epithelium.Understanding photoreceptor outer segment phagocytosis: use and utility of RPE cells in culture.Identification of miRNA signatures during the differentiation of hESCs into retinal pigment epithelial cells.Engineering efficient retinal pigment epithelium differentiation from human pluripotent stem cells.The new paradigm: retinal pigment epithelium cells generated from embryonic or induced pluripotent stem cells.Integrated analysis of DNA methylation and RNA transcriptome during in vitro differentiation of human pluripotent stem cells into retinal pigment epithelial cellsProof of concept for AAV2/5-mediated gene therapy in iPSC-derived retinal pigment epithelium of a choroideremia patient.Microarray characterization of human embryonic stem cell--derived retinal cultures.RPE and neuronal differentiation of allotransplantated porcine ciliary epithelium-derived cells.Use of human pluripotent stem cells to study and treat retinopathiesA FOXM1 Dependent Mesenchymal-Epithelial Transition in Retinal Pigment Epithelium Cells.Using Stem Cells to Model Diseases of the Outer RetinaCommon micro RNAs (miRNAs) target complement factor H (CFH) regulation in Alzheimer's disease (AD) and in age-related macular degeneration (AMD)Generation of retinal pigment epithelial cells from small molecules and OCT4 reprogrammed human induced pluripotent stem cells.Temperature-sensitive retinoid isomerase activity of RPE65 mutants associated with Leber Congenital AmaurosisOptic vesicle-like structures derived from human pluripotent stem cells facilitate a customized approach to retinal disease treatment.Modeling autosomal dominant optic atrophy using induced pluripotent stem cells and identifying potential therapeutic targetsA gene expression profile of the developing human retinal pigment epithelium.Looking into the future: Using induced pluripotent stem cells to build two and three dimensional ocular tissue for cell therapy and disease modelingA simple and scalable process for the differentiation of retinal pigment epithelium from human pluripotent stem cells.Engineering a blood-retinal barrier with human embryonic stem cell-derived retinal pigment epithelium: transcriptome and functional analysisNanofiber Scaffold-Based Tissue-Engineered Retinal Pigment Epithelium to Treat Degenerative Eye Diseases.In Pursuit of Authenticity: Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Clinical Applications.Human RPE stem cells grown into polarized RPE monolayers on a polyester matrix are maintained after grafting into rabbit subretinal space.Matrix metalloproteinase activity creates pro-angiogenic environment in primary human retinal pigment epithelial cells exposed to complement.Inhibition by miR-410 facilitates direct retinal pigment epithelium differentiation of umbilical cord blood-derived mesenchymal stem cells.Pluripotent human stem cells for the treatment of retinal disease.Ocular epithelial transplantation: current uses and future potential.Stem cell-based treatment in geographic atrophy: promises and pitfalls.Emerging options for the management of age-related macular degeneration with stem cells.Retinal repair with induced pluripotent stem cells.Cultured primary human fetal retinal pigment epithelium (hfRPE) as a model for evaluating RPE metabolism.Human pluripotent stem cell-derived retinal pigmented epithelium in retinal treatment: from bench to bedside.Integrated transcriptome analysis of human iPS cells derived from a fragile X syndrome patient during neuronal differentiation.
P2860
Q26828014-67A06E62-8F79-4DA7-B109-346F15C5E5E0Q26865154-0345D2BF-BE1C-49F1-8FCD-C8C0EA9206E3Q27015087-6B92A86C-8283-4D2A-A06B-6AA1686A33F3Q28073316-74899289-AF59-4358-AE8D-B90429D56BACQ33655064-D15B9F79-4BF0-4336-9DF9-50F2347B526BQ33846472-45BC66DD-FDE6-4E49-9DDA-CD6B6F4DE5D5Q33975601-6542BDED-8615-4BCA-847F-20E19535E5D9Q34090518-AB4DCCC0-C225-4C7A-B217-EA79A456A36FQ34357703-E92EA289-F10A-45A2-B698-5941D67A319BQ34429005-3F474377-0174-40F7-9EF3-41DC4206778CQ34494259-49C14AAB-11D2-4057-831F-33481735B75AQ35123205-80A1939A-8D01-4692-AB94-F76AE9D7236EQ35184151-977B9A89-36FA-4F5B-8A3C-0DA78DE98F2AQ35220877-CCA58B12-C00C-42AF-870A-EAA58D86322BQ35411129-02209AE9-C8C5-4A79-8B09-3112543E8A2DQ35501343-30809F35-70AC-4B49-AF8C-59F226E181FBQ35677149-C280C7BE-F317-4F00-853E-02DCA8FD7D6BQ35768469-3B2BF52B-8B93-40D1-81F7-9D618EF7B31BQ35887465-40053CE0-52E6-4B79-8BCB-AB9D9CEAD3E3Q35894518-2927127E-E586-4288-80E1-62AAB107FEF8Q35894908-CE204752-642F-4004-89AE-0224D003CCF0Q36143248-5F93FF6F-A955-48D9-85A2-735C66867AE9Q36439203-B73EC5B6-292E-4F13-A304-DD8CDBE11DD3Q36676689-67390BDC-4ABE-4DFC-AD68-F2F39152712BQ36813794-16736DD3-9326-4C8E-823D-289DA5D514FCQ36886793-5111A1CE-F3E0-4A77-9810-307EB6E75A53Q36971674-70360CE5-683B-4EEE-AC56-E3B0A879FCD1Q36996228-8602ECEF-DD01-4EF0-90F4-FB0E44442022Q37350710-A39FDEFA-4EE4-4E98-85A8-EB8D8E8C84BCQ37564296-99888E7B-9F7D-492B-95CD-5A846F0BE7D8Q37716557-5D499290-8773-4C18-9C4D-34CA26144978Q37721193-8CDB7358-3F6C-4921-AA24-99560210216AQ37869018-CE68A24C-9B04-45F1-8637-ECE9DF0F9F70Q37952317-E7329488-8435-4167-A847-C036C7413AA4Q38124462-AC1B3000-42C6-43BB-BD5F-4AB31AA8D397Q38160460-4D248832-DB43-42FE-9B89-0F265C92D825Q38167541-D2D6A7C0-ACBE-4F72-A120-8519AEB86D73Q38184178-70B2163F-0FE6-4153-8526-949C19D9106DQ38201684-1EF46E26-F131-4143-A47A-7A4E05907284Q38441936-6F65524F-74EA-496B-8979-6E238F32C832
P2860
Molecular signature of primary retinal pigment epithelium and stem-cell-derived RPE cells.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Molecular signature of primary ...... d stem-cell-derived RPE cells.
@en
Molecular signature of primary ...... d stem-cell-derived RPE cells.
@nl
type
label
Molecular signature of primary ...... d stem-cell-derived RPE cells.
@en
Molecular signature of primary ...... d stem-cell-derived RPE cells.
@nl
prefLabel
Molecular signature of primary ...... d stem-cell-derived RPE cells.
@en
Molecular signature of primary ...... d stem-cell-derived RPE cells.
@nl
P2093
P2860
P356
P1476
Molecular signature of primary ...... d stem-cell-derived RPE cells.
@en
P2093
David S Williams
Gabriel H Travis
Jo-Ling Liao
Kevin Huang
Tamar Dvash
Tanja Diemer
Xian-Jie Yang
P2860
P304
P356
10.1093/HMG/DDQ341
P50
P577
2010-08-13T00:00:00Z